ArticleAlzheimer's research & therapy2018

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Susanne Ostrowitzki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.